Our Strength
Brand
- Strong brand legacy
- Strong presence in India for more than 15 years
- Globally recognized science-based company
Cost Competitive
- Our long-term connections help us to negotiate more effectively with our preferred CROs to minimize overall project cost
- Globally recognized sci
Partner CRO’s
- Various CRO partners
- Long term partnerships built with leading Indian CROs
- Globally recognized science-based company
400+ Studies
- Experience of executing 400+ studies in India.
- Globally recognized science-based company
Experience
- Capability and experience in handling complex clinical studies
- Experience of executing 400+ studies in India.
Study Planning
- Proactively planning the project to avoid risks during and after studies execution
- Experience of executi
Expertise
Extensive Expertise across clinical studies
- Phase-1 COVID Study
- Oncology Patient based studies
- PK/PD Studies in Healthy and Patient
- Oral dosage forms IR, SR and MR formulations [Tablets, Capsule, ODT, Suspension and Syrup]
- Injection, Depot Injection and Dermal Patch Studies
- Different formulation study experiences in a single study [Tablet Vs Capsule, Injection Vs Capsule and Patch Vs Tablet]
- Reference Scaling Design Studies
- Food Effect Studies
- Mixed Population Studies
- Post Menopausal Studies
- Light Sensitive studies
What We Offer?
Daewoong India partners with your organization to ensure robust compliance in clinical development across all healthcare products. We provide comprehensive guidance and support to pharmaceutical, biotechnology, and healthcare companies throughout every phase of their clinical trials.
Daewoong India has extensive experience in selecting and managing CROs, and we take responsibility for the selection and management of these CROs, ensuring compliance with quality and service deliverables. We provide end-to-end project management support for all our clinical trials and BA/BE studies.
- Pre-clinical
- SAD (Single Ascending Dose)
- MAD (Multiple Ascending Dose)
- PK/PD in Patients
- Novel Generics 505(b)(2)
- BA/BE (Healthy and Patients)
- Phase-1
- PK/PD In Healthy
- Food effect
- Drug/Drug Interaction
- Phase II – IV
- Clinical End Point
- Nutraceuticals
- Special Population
Brand
400+ Studies
Partner CRO’s
Cost Competitive
Experience
Study Planning
Brand
- Strong brand legacy
- Strong presence in India for more than 15 years
- Globally recognized science-based company
400+ Studies
- Experience of executing 400+ studies in India
Partner CRO’s
- Various CRO partners
- Long term partnerships built with leading Indian CROs
Cost Competitive
- Our long-term connections help us to negotiate more effectively with our preferred CROs to minimize overall project cost
Experience
- Capability and experience in handling complex clinical studies
Study Planning
- Proactively planning the project to avoid risks during and after studies execution
Our Collaborates
